Disease Info Card

Endolymphatic Hydrops

Information about Endolymphatic Hydrops: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Endolymphatic Hydrops

Most recent studies have shown that Endolymphatic Hydrops shares some biological mechanisms with acoustic-neuroma, atrophy, autoimmune-diseases, autoimmune-reaction, complete-hearing-loss, deafness-sudden, dizziness, ear-diseases, edema, hearing-problem, labyrinthine-disorder, labyrinthitis, meniere-disease, nystagmus, otitis-media, otosclerosis, pathologic-fistula, sensorineural-hearing-loss-(disorder), vertigo, vestibular-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Endolymphatic Hydrops, and have been seen in publications frequently: Aging, Cell Death, Dehiscence, Diuresis, Fluid Transport, Hypersensitivity, Immune Response, Inflammatory Response, Innervation, Ion Transport, Localization, Ossification, Pathogenesis, Phagocytosis, Pigmentation, Reflex, Secretion, Sensitization, Transport, Water Homeostasis

Quite a number of genes have been found to play important roles in Endolymphatic Hydrops, such as ABR, AQP2, AVP, BRD4, CAP1, CSF2, DBI, EPO, HES1, HMGCL, LAMC2, LIPC, LNPEP, SERPINB6, SGPL1, SORBS1, STS, TFF2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.